Axsome Therapeutics (AXSM) Inventory Average (2022 - 2026)

Axsome Therapeutics' Inventory Average history runs 5 years deep, the most recent figure standing at $29.7 million for Q1 2026.

• In Q1 2026, Inventory Average rose 85.49% year-over-year to $29.7 million; the TTM figure through Mar 2026 stood at $29.7 million (up 85.49% YoY), while the FY2025 annual figure was $21.8 million, up 41.48% from the prior year.
• Inventory Average came in at $29.7 million for Q1 2026 at Axsome Therapeutics, up from $25.9 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $29.7 million in Q1 2026 to a low of $6.1 million in Q1 2023.
• A 5-year average of $15.3 million and a median of $15.0 million in 2024 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average slipped 20.87% in 2023 and surged 150.55% in 2024, its largest moves.
• Axsome Therapeutics' Inventory Average stood at $9.2 million in 2022, then soared by 37.21% to $12.6 million in 2023, then increased by 19.41% to $15.0 million in 2024, then jumped by 72.39% to $25.9 million in 2025, then advanced by 14.97% to $29.7 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $29.7 million, $25.9 million, and $21.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison